-
1
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
2
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals; a randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals; a randomised placebo-controlled trial. Lancet 2002; 360: 7-22
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
3
-
-
0034603775
-
Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia
-
Strawn WB, Chappell MC, Dean RH, et al. Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 2000; 101: 1586-93
-
(2000)
Circulation
, vol.101
, pp. 1586-1593
-
-
Strawn, W.B.1
Chappell, M.C.2
Dean, R.H.3
-
4
-
-
0034711717
-
Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats
-
Usui M, Egashira K, Tomita H, et al. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats. Circulation 2000; 101: 305-10
-
(2000)
Circulation
, vol.101
, pp. 305-310
-
-
Usui, M.1
Egashira, K.2
Tomita, H.3
-
5
-
-
8644277443
-
Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients
-
Kondo J, Sone T, Tsuboi H, et al. Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients. Am Heart J 2003; 146: E20
-
(2003)
Am Heart J
, vol.146
-
-
Kondo, J.1
Sone, T.2
Tsuboi, H.3
-
6
-
-
0030926821
-
Altered plasma levels of cytokines in patients with ischemic heart disease
-
Tashiro H, Shimokawa H, Yamamoto K, et al. Altered plasma levels of cytokines in patients with ischemic heart disease. Coron Artery Dis 1997; 8: 143-7
-
(1997)
Coron Artery Dis
, vol.8
, pp. 143-147
-
-
Tashiro, H.1
Shimokawa, H.2
Yamamoto, K.3
-
7
-
-
0033600543
-
Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin
-
Ikonomidis I, Andreotti F, Economou E, et al. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 1999; 100: 793-8
-
(1999)
Circulation
, vol.100
, pp. 793-798
-
-
Ikonomidis, I.1
Andreotti, F.2
Economou, E.3
-
8
-
-
0036122383
-
Increased levels of monocyte-related cytokines in patients with unstable angina
-
Hojo Y, Ikeda U, Takahashi M, et al. Increased levels of monocyte-related cytokines in patients with unstable angina. Atherosclerosis 2002; 161: 403-8
-
(2002)
Atherosclerosis
, vol.161
, pp. 403-408
-
-
Hojo, Y.1
Ikeda, U.2
Takahashi, M.3
-
9
-
-
0035108994
-
Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty
-
Tashiro H, Shimokawa H, Sadamatsu K, et al. Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty. Coron Artery Dis 2001; 12: 107-13
-
(2001)
Coron Artery Dis
, vol.12
, pp. 107-113
-
-
Tashiro, H.1
Shimokawa, H.2
Sadamatsu, K.3
-
10
-
-
0034163470
-
Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris
-
Saitoh T, Kishida H, Tsukada Y, et al. Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris. J Am Coll Cardiol 2000; 35: 655-65
-
(2000)
J Am Coll Cardiol
, vol.35
, pp. 655-665
-
-
Saitoh, T.1
Kishida, H.2
Tsukada, Y.3
-
11
-
-
0036307946
-
Prognostic significance of plasma concentrations of transforming growth factor-β in patients with coronary artery disease
-
Tashiro H, Shimokawa H, Sadamatu K, et al. Prognostic significance of plasma concentrations of transforming growth factor-β in patients with coronary artery disease. Coron Artery Dis 2002; 13: 139-43
-
(2002)
Coron Artery Dis
, vol.13
, pp. 139-143
-
-
Tashiro, H.1
Shimokawa, H.2
Sadamatu, K.3
-
12
-
-
0030969425
-
Role of macrophage colony-stimulating factor in atherosclerosis: Studies of osteopetrotic mice
-
Qiao JH, Tripathi J, Mishra NK, et al. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am J Pathol 1997; 150: 1687-99
-
(1997)
Am J Pathol
, vol.150
, pp. 1687-1699
-
-
Qiao, J.H.1
Tripathi, J.2
Mishra, N.K.3
-
13
-
-
0031878224
-
Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo
-
Mozes G, Mohacsi T, Gloviczki P, et al. Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo. Arterioscler Thromb Vasc Biol 1998; 18: 1157-63
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 1157-1163
-
-
Mozes, G.1
Mohacsi, T.2
Gloviczki, P.3
-
14
-
-
0034821456
-
Long term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery disease
-
Sadamatsu K, Shimokawa H, Tashiro H, et al. Long term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery disease. Heart 2001; 86: 457-8
-
(2001)
Heart
, vol.86
, pp. 457-458
-
-
Sadamatsu, K.1
Shimokawa, H.2
Tashiro, H.3
-
15
-
-
0037246520
-
Inflammation in early atherogenesis: Impact of ACE inhibition
-
Caterina RD, Manes C. Inflammation in early atherogenesis: impact of ACE inhibition. Eur Heart J 2003; 5 Suppl. A: A15-24
-
(2003)
Eur Heart J
, vol.5
, Issue.SUPPL. A
-
-
Caterina, R.D.1
Manes, C.2
-
16
-
-
0032584177
-
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
-
Laufs U, Fata VL, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129-35
-
(1998)
Circulation
, vol.97
, pp. 1129-1135
-
-
Laufs, U.1
Fata, V.L.2
Plutzky, J.3
-
17
-
-
0029043048
-
Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells
-
Peng HB, Rajavashisth TB, Libby P, et al. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 1995; 270: 17050-5
-
(1995)
J Biol Chem
, vol.270
, pp. 17050-17055
-
-
Peng, H.B.1
Rajavashisth, T.B.2
Libby, P.3
-
18
-
-
0035834818
-
Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice
-
Mallat Z, Gojova A, Marchiol-Fournigault C, et al. Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001; 89: 930-4
-
(2001)
Circ Res
, vol.89
, pp. 930-934
-
-
Mallat, Z.1
Gojova, A.2
Marchiol-Fournigault, C.3
-
19
-
-
0036078307
-
Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression
-
Lutgens E, Gijbels M, Smook M, et al. Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 2002; 22: 975-82
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 975-982
-
-
Lutgens, E.1
Gijbels, M.2
Smook, M.3
-
20
-
-
4744371004
-
Increased expression of transforming growth factor-β1 as a stabilizing factor in human atherosclerotic plaques
-
Cipollone F, Fazia M, Mincione G, et al. Increased expression of transforming growth factor-β1 as a stabilizing factor in human atherosclerotic plaques. Stroke 2004; 35: 2253-7
-
(2004)
Stroke
, vol.35
, pp. 2253-2257
-
-
Cipollone, F.1
Fazia, M.2
Mincione, G.3
-
21
-
-
0035177661
-
Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats
-
Satoh C, Fukuda N, Hu WY, et al. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol 2001; 37: 108-18
-
(2001)
J Cardiovasc Pharmacol
, vol.37
, pp. 108-118
-
-
Satoh, C.1
Fukuda, N.2
Hu, W.Y.3
-
22
-
-
0031814542
-
Early induction of transforming growth factor-β via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats
-
Tomita H, Egashira K, Ohara Y, et al. Early induction of transforming growth factor-β via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 1998; 32: 273-9
-
(1998)
Hypertension
, vol.32
, pp. 273-279
-
-
Tomita, H.1
Egashira, K.2
Ohara, Y.3
-
23
-
-
0141792887
-
Effect of angiotensin II receptor blocker on plasma levels of TGF-β1 and interstitial fibrosis in hypertensive kidney transplant patients
-
El-Agroudy AE, Hassan NA, Foda MA, et al. Effect of angiotensin II receptor blocker on plasma levels of TGF-β1 and interstitial fibrosis in hypertensive kidney transplant patients. Am J Nephrol 2003; 23: 300-6
-
(2003)
Am J Nephrol
, vol.23
, pp. 300-306
-
-
El-Agroudy, A.E.1
Hassan, N.A.2
Foda, M.A.3
-
24
-
-
0032784820
-
Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy
-
Campistol JM, Iñigo P, Jimenez W, et al. Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy. Kidney Int 1999; 56: 714-9
-
(1999)
Kidney Int
, vol.56
, pp. 714-719
-
-
Campistol, J.M.1
Iñigo, P.2
Jimenez, W.3
-
25
-
-
0037024272
-
Increased transforming growth factor-beta1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibition with pravastatin
-
Porreca E, Febbo CD, Baccante G, et al. Increased transforming growth factor-beta1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibition with pravastatin. J Am Coll Cardiol 2002; 39: 1752-7
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 1752-1757
-
-
Porreca, E.1
Febbo, C.D.2
Baccante, G.3
-
26
-
-
33644874726
-
Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution
-
Sales VL, Sukhova GK, Lopez-Ilasaca AL, et al. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 2005; 112: 3328-36
-
(2005)
Circulation
, vol.112
, pp. 3328-3336
-
-
Sales, V.L.1
Sukhova, G.K.2
Lopez-Ilasaca, A.L.3
-
27
-
-
0033533456
-
Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) pilot study
-
The RESOLVD pilot study investigators. Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) pilot study. Circulation 1999; 100: 1056-64
-
(1999)
Circulation
, vol.100
, pp. 1056-1064
-
-
-
28
-
-
0038730605
-
Inhibition of the renin-angiotensin system: No effect on circulating macrophage colony-stimulating factor levels in acute myocardial infarction
-
Kurosaki K, Ikeda U, Murakami Y, et al. Inhibition of the renin-angiotensin system: no effect on circulating macrophage colony-stimulating factor levels in acute myocardial infarction. J Cardiovasc Pharmacol 2003; 42: 37-41
-
(2003)
J Cardiovasc Pharmacol
, vol.42
, pp. 37-41
-
-
Kurosaki, K.1
Ikeda, U.2
Murakami, Y.3
-
29
-
-
0032849727
-
Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries
-
Erren M, Reinecke H, Junker R, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19: 2355-63
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 2355-2363
-
-
Erren, M.1
Reinecke, H.2
Junker, R.3
-
30
-
-
0028918825
-
The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis
-
Grainger DJ, Kemp PR, Metcalfe JC, et al. The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med 1995; 1: 74-9
-
(1995)
Nat Med
, vol.1
, pp. 74-79
-
-
Grainger, D.J.1
Kemp, P.R.2
Metcalfe, J.C.3
-
31
-
-
0030994625
-
Circulating transforming growth factor β 1 and coronary artery disease
-
Wang XL, Liu SX, Wilcken DEL. Circulating transforming growth factor β 1 and coronary artery disease. Cardiovasc Res 1997; 34: 404-10
-
(1997)
Cardiovasc Res
, vol.34
, pp. 404-410
-
-
Wang, X.L.1
Liu, S.X.2
Wilcken, D.E.L.3
-
32
-
-
0034690805
-
Association of a T29 C polymorphism of the transforming growth factor-β 1 gene with genetic susceptibility to myocardial infarction in Japanese
-
Yokota M, Ichihara S, Lin TL, et al. Association of a T29 C polymorphism of the transforming growth factor-β 1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000; 101: 2783-7
-
(2000)
Circulation
, vol.101
, pp. 2783-2787
-
-
Yokota, M.1
Ichihara, S.2
Lin, T.L.3
-
33
-
-
0038344675
-
Antiatherosclerotic effects of β-blockers
-
Wikstrand J, Berglund G, Hedblad B, et al. Antiatherosclerotic effects of β-blockers. Am J Cardiol 2003; 91 Suppl.: 25-9H
-
(2003)
Am J Cardiol
, vol.91
, Issue.SUPPL.
-
-
Wikstrand, J.1
Berglund, G.2
Hedblad, B.3
-
34
-
-
0027163945
-
Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury
-
U S A
-
Ohlstein EH, Douglas SA, Sung CP, et al. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. Proc Natl Acad Sci U S A 1993; 90 (13): 6189-93
-
(1993)
Proc Natl Acad Sci
, vol.90
, Issue.13
, pp. 6189-6193
-
-
Ohlstein, E.H.1
Douglas, S.A.2
Sung, C.P.3
-
35
-
-
0842311007
-
Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan
-
Jinno T, Iwai M, Li Z, et al. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan. Hypertension 2004; 43: 263-9
-
(2004)
Hypertension
, vol.43
, pp. 263-269
-
-
Jinno, T.1
Iwai, M.2
Li, Z.3
-
36
-
-
0033039589
-
Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects
-
Nazzaro P, Manzari M, Merlo M, et al. Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects. Hypertension 1999; 33: 719-25
-
(1999)
Hypertension
, vol.33
, pp. 719-725
-
-
Nazzaro, P.1
Manzari, M.2
Merlo, M.3
|